Neil Eisberg US chemical major Huntsman has acquired the Baroda Division of Indian dyestuffs producer Metrochem Industries, including a facility for the production of textile intermediates and spec...
Danish pharma concern H Lundbeck has acquired Aarhus-based biotech firm Neuronicon, which specialises in the treatment of brain damage following strokes and skull fractures. Lundbeck has also signed a...
Neil Eisberg Portuguese supplier of active pharmaceutical ingredients (APIs), Hovione has acquired Pfizer’s Loughbeg API facility near Cork in Ireland in a deal expected to be completed by early Ap...
Belgian biopharma concern UCB is seeking to acquire the remaining outstanding shares it doesn’t hold, around 0.4% of the total stock, of German pharma firm Schwarz Pharma for €111.44/share. Follo...
Japanese pharma major Dainippon Sumitomo is acquiring US speciality pharma company Sepracor for $2.6bn.
Neil Eisberg Dutch chemical major AkzoNobel is acquiring German-based LII Europe, which operates a multi-client chlorine cluster on the Hoechst Industrial Park near Frankfurt. LII Europe also opera...
Chemicals company executives are no strangers to cyclical downturns but the current situation is considerably more serious than anything that the industry has encountered before. Since mid-2008, globa...
US life science major Monsanto has acquired the assets of WestBred, a Montana-based company specialising in wheat germplasm, the crop’s seed genetic material, for $45m. The company was owned indirectl...